Regulations

FDA FDA Approval Drug Safety Drug Approval Medical Procedures Licensing Therapeutic Goods Administration Safety Standards FDA Decisions FDA Warnings FDA Clearance Medicare Coverage Criminal Safety Failings National Health Service Environmental Regulations FDA Regulations Medication Approval Process Abortion Laws Noncompete Agreements Cosmetic Treatments Affordable Care Act European Medicines Agency FDA Recall Maternal Health Medicines Safety Abortion Services Medicare Billing Practices Department of Justice Cosmetic Industry Nursing Home Inspections Government Agencies Online Medicine Sales Employment Contracts Medicare Drug Control FDA Oversight Professional Titles Information Collection Anvisa Clinical Practices Sanitary Standards Pharmacy Laws Medical Safety FDA Guidelines Healthcare Policies Transgender Medicine Substance Use Drug Regulations Price Transparency Prescription Medications

FDA Class II Recall Issued for 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

Regulators urge patients to consult a clinician before making any medication changes.

Chinese Weight-Loss Drug Suppliers Pivot to Generics as U.S. Crackdown Ends Copycat Boom